Pediatric Pulmonology, Sidra Medicine, Doha, Qatar.
Pediatric Pulmonology, Hamad Medical Corporation, Doha, Qatar.
Pulm Med. 2022 Dec 1;2022:6558309. doi: 10.1155/2022/6558309. eCollection 2022.
This is a retrospective review of the medical electronic charts of patients with TEF that were followed at Sidra Medicine in the state of Qatar. The review included the patients who were operated upon in the period of 2011-2021 but continued to follow at our institution in the period of 2018-2021. Demographic data, associated anomalies, preoperative, operative, and postoperative courses, and growth parameters were collected.
A total of 35 patients with TEF (24 males and 11 females) were collected. 49% were full term. We identified seven patients (20%) with isolated TEF, TEF with VACTERL association in 29% of our patients, other chromosomal anomalies in 17%, or associated with other anomalies (not related to VACTERL) in 34% of the patients. The majority of the patients (94%) were of type C-TEF (TEF with esophageal atresia-EA/TEF). All patients were operated except for one patient who died at 2 days of life due to cardiac complications. Median age at which surgery was performed was 2 days (range 1-270 days). Median follow-up was 32 months (range 7-115 months). Immediate postoperative complications were encountered in eleven patients (33%) and included anastomosis leak in 12%, air leak in 6%, sepsis in 6%, chylothorax in 3%, vocal cord palsy and fistula recurrence (combined) in 3%, and failure of TEF closure in 3% of the patients. Long-term respiratory complications were encountered in 43% of our patients. Long-term gastrointestinal complications included gastroesophageal reflux (GERD) in 63%, dysphagia in 31%, and anastomotic stricture in 34% of the patients. Growth was affected in around a quarter of the patients at 6 months after surgery and 22% at 12-month assessment postoperatively. While only five patients died at our institution, only one was directly related to failure of TEF closure and postoperative complications.
This descriptive study reports the clinical outcome of TEF from a rapidly developing country. The distribution of the patients' characteristics and postoperative complications was almost comparable to those from developed countries. This study would aid in addressing the prognostic factors and establishment of evidence-based management pathways of newborns with TEF to improve the clinical outcome in our center and other pediatric tertiary centers in developing countries.
这是对在卡塔尔锡德拉医学中心接受治疗的 TEF 患者的医学电子病历进行的回顾性研究。本研究纳入了于 2011 年至 2021 年期间接受手术但在 2018 年至 2021 年期间仍在我院接受随访的患者。收集了患者的人口统计学数据、相关异常、术前、术中和术后经过以及生长参数。
共收集了 35 例 TEF(24 名男性和 11 名女性)患者。49%为足月产。我们发现 7 例(20%)为单纯 TEF,29%的患者 TEF 合并 VACTERL 畸形,17%存在染色体异常,34%的患者存在其他(与 VACTERL 无关)异常。大多数患者(94%)为 C 型 TEF(食管闭锁-TEF/TEF)。除了 1 例在出生后 2 天因心脏并发症死亡的患者外,其余患者均接受了手术治疗。手术时的中位年龄为 2 天(范围为 1-270 天)。中位随访时间为 32 个月(范围为 7-115 个月)。11 例(33%)患者发生术后早期并发症,包括吻合口漏 12%、气胸 6%、败血症 6%、乳糜胸 3%、声带麻痹和瘘管复发(联合)3%、TEF 关闭失败 3%。43%的患者出现长期呼吸系统并发症。长期胃肠道并发症包括胃食管反流病(GERD)63%、吞咽困难 31%和吻合口狭窄 34%。术后 6 个月有四分之一的患者生长受到影响,术后 12 个月有 22%的患者生长受到影响。虽然我院有 5 例患者死亡,但只有 1 例与 TEF 关闭失败和术后并发症直接相关。
本描述性研究报告了一个快速发展中国家 TEF 的临床结果。患者的特征和术后并发症的分布与发达国家几乎相当。本研究将有助于确定新生儿 TEF 的预后因素和建立循证管理途径,以改善我院和发展中国家其他儿科三级中心的临床结局。